August 29, 2018Open Access

Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder

Key Points

Key points are not available for this paper at this time.

Abstract

Prazosin holds promise as a harm-reduction pharmacologic treatment for alcohol use disorder and deserves further evaluation by independent research groups.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

Cite This Study

Simpson et al. (Wed,) studied this question.

synapsesocial.com/papers/69d898b6de3177251abeda9b https://doi.org/https://doi.org/10.1176/appi.ajp.2018.17080913

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder2018 · 49 citations
2<scp>E</scp>nv<scp>S</scp>tats, an<scp>R</scp><scp>P</scp>ackage for<scp>E</scp>nvironmental<scp>S</scp>tatistics2014 · 114 citations
3α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates2002 · 292 citations
4Prazosin selectively antagonizes neuronal responses mediated by ?1-adrenoceptors in brain1981 · 125 citations
5Measurement of drinking behavior using the Form 90 family of instruments.1994 · 451 citations